Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 1
1996 2
1997 3
1998 4
1999 3
2000 2
2001 1
2002 6
2003 4
2004 9
2005 9
2006 4
2007 3
2008 5
2009 2
2010 11
2011 9
2012 15
2013 7
2014 7
2015 6
2016 4
2017 3
2018 1
2019 3
2020 1
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study.
Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, Chang YM, Fink AM, Tausch E, Schneider C, Ritgen M, Kreuzer KA, Sivcheva L, Niemann CU, Schwarer AP, Loscertales J, Weinkove R, Strumberg D, Kilfoyle A, Manzoor BS, Jawaid D, Emechebe N, Devine J, Boyer M, Runkel ED, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek MJ, Fischer K. Al-Sawaf O, et al. Among authors: strumberg d. Blood. 2024 Jul 10:blood.2024024631. doi: 10.1182/blood.2024024631. Online ahead of print. Blood. 2024. PMID: 39082668 Free article.
Regorafenib for cancer.
Strumberg D, Schultheis B. Strumberg D, et al. Expert Opin Investig Drugs. 2012 Jun;21(6):879-89. doi: 10.1517/13543784.2012.684752. Expert Opin Investig Drugs. 2012. PMID: 22577890 Review.
Raf kinase inhibitors in oncology.
Strumberg D, Seeber S. Strumberg D, et al. Onkologie. 2005 Feb;28(2):101-7. doi: 10.1159/000083373. Onkologie. 2005. PMID: 15665559 Review.
Sorafenib for the treatment of renal cancer.
Strumberg D. Strumberg D. Expert Opin Pharmacother. 2012 Feb;13(3):407-19. doi: 10.1517/14656566.2012.654776. Epub 2012 Jan 20. Expert Opin Pharmacother. 2012. PMID: 22263843 Review.
Metal-dependent inhibition of HIV-1 integrase.
Neamati N, Lin Z, Karki RG, Orr A, Cowansage K, Strumberg D, Pais GC, Voigt JH, Nicklaus MC, Winslow HE, Zhao H, Turpin JA, Yi J, Skalka AM, Burke TR Jr, Pommier Y. Neamati N, et al. Among authors: strumberg d. J Med Chem. 2002 Dec 19;45(26):5661-70. doi: 10.1021/jm0201417. J Med Chem. 2002. PMID: 12477350
Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors.
Díaz-Carballo D, Saka S, Acikelli AH, Homp E, Erwes J, Demmig R, Klein J, Schröer K, Malak S, D'Souza F, Noa-Bolaño A, Menze S, Pano E, Andrioff S, Teipel M, Dammann P, Klein D, Nasreen A, Tannapfel A, Grandi N, Tramontano E, Ochsenfarth C, Strumberg D. Díaz-Carballo D, et al. Among authors: strumberg d. Commun Biol. 2021 Mar 3;4(1):276. doi: 10.1038/s42003-021-01800-3. Commun Biol. 2021. PMID: 33658617 Free PMC article.
117 results